BIOVIAN News and Resources

Biovian and 3P Biopharmaceuticals, biologics Contract Development and Manufacturing Organisations (CDMOs), announced their combination to establish a new pan-European leader in their field. This strategic move was backed by their common shareholder, Keensight Capital. The newly formed group, named 3PBIOVIAN, will offer